Welcome to our dedicated page for Diebold Nixdorf SEC filings (Ticker: DBD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Diebold Nixdorf, Incorporated (NYSE: DBD) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures filed with the U.S. Securities and Exchange Commission. As a public company that automates, digitizes and transforms the way people bank and shop, Diebold Nixdorf uses SEC filings to report financial results, material events and changes in executive leadership, among other topics.
Current reports on Form 8-K are a key source of timely information. Diebold Nixdorf files 8-Ks under Item 2.02 to furnish quarterly results of operations and financial condition, typically referencing attached news releases that summarize revenue trends, earnings metrics and free cash flow performance. These filings help investors locate official announcements about quarterly performance and related commentary. The company also uses Item 5.02 of Form 8-K to disclose departures and appointments of certain officers, including changes in roles such as Chief Revenue Officer and Chief Operating Officer, along with references to relevant employment agreements.
In addition to 8-Ks, investors may review the company’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which provide more detailed financial statements, segment information for Banking and Retail, and discussions of risk factors and business operations. Proxy statements and related filings can offer insight into executive compensation and governance practices, while Forms 3, 4 and 5 (when filed) provide information on insider share transactions.
On Stock Titan, Diebold Nixdorf filings are complemented by AI-powered summaries that explain the key points of lengthy documents such as 10-Ks and 10-Qs in plain language. Real-time updates from EDGAR help ensure that newly filed 8-Ks, periodic reports and any insider trading forms are quickly available. This allows users to review the regulatory record of DBD and understand how the company communicates financial results, leadership changes and other material information.
Diebold Nixdorf, Incorporated has called its 2026 annual stockholder meeting for May 22, 2026, at 8:00 a.m. EDT as a fully virtual event. Stockholders of record on March 23, 2026 can vote online, by phone, by mail, or during the meeting.
Investors are being asked to elect eight directors, ratify KPMG LLP as independent auditor for 2026, and approve, on a non-binding advisory basis, compensation for named executive officers. The Board recommends voting FOR all three proposals. The proxy highlights 2025 as a year of consistent results, stronger free cash flow and a more resilient balance sheet, including record free cash flow of $239 million and credit rating upgrades that support the company’s stated focus on profitable growth and disciplined capital deployment.
The Vanguard Group filed an amendment (Schedule 13G/A) reporting 0 shares of Diebold Nixdorf Inc. common stock. The filing states 0 beneficially owned and 0.00% of the class. It notes an internal realignment on January 12, 2026 that caused disaggregated reporting by Vanguard subsidiaries.
The filing is signed by Ashley Grim as Head of Global Fund Administration on 03/26/2026.
DIEBOLD NIXDORF, Inc executive Andrew Joseph Zosel filed an initial Form 3 reporting his beneficial ownership position in the company’s common stock. The filing shows he holds no shares of Diebold Nixdorf common stock directly following the reported date.
Zosel Andrew Joseph reported acquisition or exercise transactions in this Form 4 filing.
Diebold Nixdorf EVP and Chief Product & Technology Officer Andrew Joseph Zosel received an equity grant of 6,561 shares of common stock. The award consists of Restricted Stock Units granted under the 2023 Equity and Incentive Plan and vests in three equal annual installments beginning one year from the grant date.
Each Restricted Stock Unit represents a contingent right to receive one share of Diebold Nixdorf common stock. Following this grant, Zosel directly holds 6,561 shares, a figure that includes these Restricted Stock Units.
DIEBOLD NIXDORF, Inc executive Jeffrey M. Sesplankis, the company’s SVP and Chief Accounting Officer, filed an initial statement of beneficial ownership of securities. The Form 3 reports direct ownership of 5,801 shares of Common Stock, and a footnote states this number includes Restricted Stock Units.
Diebold Nixdorf, Inc. President and CEO Octavio Marquez reported a Form 4 showing a tax-withholding disposition of 10,549 shares of common stock at $77.58 per share. According to the footnote, these shares were withheld to satisfy tax obligations under the company’s 2023 Equity and Incentive Plan, as amended, rather than sold in an open-market transaction.
After this withholding, Marquez directly holds a total of 216,257 shares of common stock, a figure that the disclosure notes also includes Restricted Stock Units. This filing reflects routine equity award tax administration rather than a discretionary share sale.
Diebold Nixdorf, Inc. senior vice president and chief accounting officer Jeffrey M. Sesplankis reported routine equity compensation-related transactions in company common stock. On March 1, 2026, 672 shares were disposed of at $80.00 per share to satisfy tax withholding obligations under the 2023 Equity and Incentive Plan.
The same day, he acquired a grant of 2,215 restricted stock units (RSUs) at no cost under the 2023 Equity and Incentive Plan, vesting in three equal annual installments beginning one year from the grant date. Following these transactions, his directly held holdings, including RSUs, total 7,344 shares of common stock.
Diebold Nixdorf EVP Elizabeth Christine Radigan reported compensatory stock transactions. On the reported date, 1,944 shares of common stock were disposed of to cover tax withholding obligations under the company’s 2023 Equity and Incentive Plan. She also acquired 6,607 restricted stock units as a grant, which vest in three equal annual installments beginning one year from the grant date. Following these transactions, her directly held and reported holdings, which include restricted stock units, increased to 28,553 shares of common stock equivalents.
Diebold Nixdorf, Inc. President and CEO Octavio Marquez reported two equity transactions in common stock. First, 9,119 shares were withheld at $80.00 per share to cover tax obligations under the 2023 Equity and Incentive Plan. Second, he received an award of 44,286 Restricted Stock Units at no purchase price, which vest in three equal annual installments starting one year from the grant date, with each unit representing the right to receive one share of common stock.
Diebold Nixdorf EVP and CFO Thomas S. Timko reported two equity-related transactions in company common stock. On March 1, 2026, 7,553 shares were disposed of at $80.00 per share to satisfy tax withholding obligations under the 2023 Equity and Incentive Plan. This was a tax-withholding disposition, not an open-market sale, and left him with 59,500 shares, including restricted stock units.
On the same date, Timko acquired a grant of 15,308 restricted stock units with no cash price, under the Diebold Nixdorf, Incorporated 2023 Equity and Incentive Plan. These RSUs vest in three equal annual installments beginning one year from the grant date, with each unit representing a contingent right to receive one share of common stock. Following this award, his direct holdings, including RSUs, increased to 74,808 shares.